#fda approval

[healthtruth101]

This used to be #RED40 until our previous 'fda' banned it and started using the petroleum based red dye because they were polluting the rivers and needed a new use for the byproduct in factories. Just like FLOURIDE. #healthiswealth

Red Amaranth plant

[aci25]

More Proof That Something Is Very Wrong With the Food in America

It is great to see a growing public awareness regarding the quality of our food systems, a critical issue that has been documented for decades by investigative works like Food Inc., Super Size Me, Cowspiracy: The Sustainability Secret and Rotten.

The core of the problem lies in the relationship between the food industry and our political leadership. Regardless of party affiliation, many lawmakers are heavily influenced by corporate lobbying and campaign financing, which often prioritizes industry profits over public health. Consequently, regulatory bodies like the FDA frequently fail to provide the oversight necessary to protect consumers.

To address this, it is vital to translate our collective frustration into informed civic action. We must hold our elected officials accountable at the ballot box and demand comprehensive legislative reforms and stricter regulations on the food industry to ensure the well-being of all citizens.

[letterstothefutureme]

FDA approves first ever OTC Birth Control pill.

[pozmagazine]

FDA Approves Once-Daily Descovy for PrEP

The new indication is for prevention of sexually transmitted HIV, with the exception of transmission via receptive vaginal sex.

The Food and Drug Administration (FDA) has approved daily Descovy (tenofovir alafenamide/emtricitabine) as a second pre-exposure prophylaxis (PrEP) option for most people.

Descovy is now approved for adults and adolescents weighing at least 35 kilograms, or about 77 pounds, to reduce the risk of contracting HIV via sex, with the exception of receptive vaginal sex. It should be taken once daily with or without food. Intermittent or on-demand use of Descovy before and after sex is not included in the approval. People wishing to use Descovy for PrEP should be tested to ensure than they are in fact HIV negative.

[intelligentliving]

Alzheimer's Drug Pending FDA Approval After Clinical Trial Revealed Cognitive Improvement

The experimental medication for Alzheimer's called Aducanumab by Biogen improved cognition substantially in the participants of a Phase 3 Clinical Trial.

[gomerblogworld]

Read more: http://bit.ly/2XwQFl8

Dilaumorfentanylocet approved for 11/10 pain and above

https://gomerblog.com/wp-content/uploads/2017/03/pills.jpg

In an exciting development for doctors and nurses around the country, FDA has approved a powerful new drug for treatment of resistant pain, defined as pain of 11 and above on the scale of 10. Dilaumorfentanyloce was tested in a large multicenter clinical trial and used to treat a broad range of...

Read more on https://gomerblog.com/2019/07/dilaumorfentanylocet-approved-for-11-10-pain-and-above/?utm_source=TR&utm_campaign=DIRECT

www.gomerblog.com

[pozmagazine]

Coronavirus Antibody Tests Could Be a Game Changer

Tests like the one approved this week can show who is likely to be immune, but it's not yet clear how long such immunity lasts.

On April 1, the Food and Drug Administration (FDA) granted its first emergency use authorization for a test that detects antibodies against the new coronavirus that causes the respiratory illness known as COVID-19. This type of test is already being used in other countries.

Unlike the tests now in use in the United States, which detect current active infection, antibody tests reveal whether someone has ever contracted the coronavirus (officially known as SARS-CoV-2), including those who have recovered. It could potentially be used to show who is now immune and therefore can safely let up on social distancing.

The FDA previously authorized several PCR RNA tests, which detect genetic material from the virus in a nasal swab sample. These are similar to the viral load tests used to show whether HIV or hepatitis C treatment is working, though those tests use a blood sample.

[pozmagazine]

Canada Is the First to Approve Long-Acting HIV Regimen Cabenuva

The FDA recently held up the U.S. approval based on concerns over the monthly injectable regimen’s manufacturing.

HIV treatment has entered an exciting new era as Canada has become the first nation in the world to approve ViiV Healthcare’s monthly long-acting injectable antiretroviral (ARV) regimen Cabenuva (cabotegravir/rilpivirine)—the first complete regimen for treating the virus that does not require daily pills.

In late December, the Food and Drug Administration (FDA) held up approval of the regimen, citing concerns over its manufacturing process. In turn, ViiV indicated it was working closely with the FDA to address those concerns and ultimately bring Cabenuva to market in the United States.

ViiV first applied for FDA approval of Cabenuva in April 2019.